WallStreetZenWallStreetZen

NASDAQ: AZR
Azora Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AZR

Based on 2 analysts offering 12 month price targets for Azora Therapeutics Inc

Min Forecast
$6.00+57.48%
Avg Forecast
$8.50+123.1%
Max Forecast
$11.00+188.71%

Should I buy or sell AZR stock?

Based on 2 analysts offering ratings for Azora Therapeutics Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AZR stock forecasts and price targets.

AZR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-03
lockedlocked$00.00+00.00%2026-06-15

1 of 1

Forecast return on equity

Is AZR forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is AZR forecast to generate an efficient return on assets?

Company
-17.31%
Industry
21.92%
AZR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AZR earnings per share forecast

What is AZR's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$4.01
Avg 2 year Forecast
-$1.26
Avg 3 year Forecast
-$1.21

AZR revenue forecast

What is AZR's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

AZR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AZR$4.88$8.50+74.18%Strong Buy
KAPA$0.54N/AN/A
LPCN$1.52$4.00+163.16%Hold
DYAI$0.36N/AN/A
GUTS$0.99$46.75+4,612.70%Buy
View Top Biotech Stocks

Azora Therapeutics Stock Forecast FAQ

Is Azora Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AZR) stock is to Strong Buy AZR stock.

Out of 2 analysts, 2 (100%) are recommending AZR as a Strong Buy, 0 (0%) are recommending AZR as a Buy, 0 (0%) are recommending AZR as a Hold, 0 (0%) are recommending AZR as a Sell, and 0 (0%) are recommending AZR as a Strong Sell.

If you're new to stock investing, here's how to buy Azora Therapeutics stock.

What is AZR's earnings growth forecast for 2026-2028?

(NASDAQ: AZR) Azora Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.56%.

Azora Therapeutics's earnings in 2026 is -$57,801,206.On average, 6 Wall Street analysts forecast AZR's earnings for 2026 to be -$10,526,143, with the lowest AZR earnings forecast at -$18,245,209, and the highest AZR earnings forecast at -$2,895,044. On average, 5 Wall Street analysts forecast AZR's earnings for 2027 to be -$3,312,298, with the lowest AZR earnings forecast at -$6,407,697, and the highest AZR earnings forecast at -$1,571,595.

In 2028, AZR is forecast to generate -$3,173,913 in earnings, with the lowest earnings forecast at -$4,400,466 and the highest earnings forecast at -$1,819,742.

What is AZR's revenue growth forecast for 2026-2028?

(NASDAQ: AZR) Azora Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.98%.

Azora Therapeutics's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast AZR's revenue for 2026 to be $0, with the lowest AZR revenue forecast at $0, and the highest AZR revenue forecast at $0. On average, 4 Wall Street analysts forecast AZR's revenue for 2027 to be $0, with the lowest AZR revenue forecast at $0, and the highest AZR revenue forecast at $0.

In 2028, AZR is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is AZR's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: AZR) forecast ROA is -17.31%, which is lower than the forecast US Biotechnology industry average of 22.87%.

What is AZR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AZR price target, the average AZR price target is $8.50, with the highest AZR stock price forecast at $11.00 and the lowest AZR stock price forecast at $6.00.

On average, Wall Street analysts predict that Azora Therapeutics's share price could reach $8.50 by Aug 3, 2027. The average Azora Therapeutics stock price prediction forecasts a potential upside of 74.18% from the current AZR share price of $4.88.

What is AZR's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AZR) Azora Therapeutics's current Earnings Per Share (EPS) is -$15.46. On average, analysts forecast that AZR's EPS will be -$4.01 for 2026, with the lowest EPS forecast at -$6.95, and the highest EPS forecast at -$1.10. On average, analysts forecast that AZR's EPS will be -$1.26 for 2027, with the lowest EPS forecast at -$2.44, and the highest EPS forecast at -$0.60. In 2028, AZR's EPS is forecast to hit -$1.21 (min: -$1.68, max: -$0.69).

What is AZR's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: AZR) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.